{
    "clinical_study": {
        "@rank": "159580", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "description": "Women treated with Menopur"
            }, 
            {
                "arm_group_label": "Group 2", 
                "description": "Women treated with Menopur and Bravelle"
            }
        ], 
        "brief_summary": {
            "textblock": "This post-marketing, single-center prospective study will be conducted in an open-label,\n      non-interventional setting, for women seeking fertility treatment and will describe cleavage\n      dynamics in relation to the age of the oocyte and gonadotrophin treatment."
        }, 
        "brief_title": "Study of the Cleavage of the Egg in Relation to the Stimulation Treatment", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Female Infertility", 
        "condition_browse": {
            "mesh_term": [
                "Infertility", 
                "Infertility, Female"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. IVF/ICSI treatment\n\n          2. Regular cycles of 25-35 days\n\n          3. Follicle stimulation with Bravelle and/or Menopur\n\n          4. Women aged 38-35 years\n\n          5. Long agonist or short antagonist treatment\n\n          6. Willing and able to understand a Danish, English or German patient information form\n\n          7. Willing and able to provide written Informed Consent\n\n        Exclusion Criteria:\n\n          1. BMI more than 35\n\n          2. Presence of hydrosalpinx on ultrasound\n\n          3. FSH more than 13 or antral follicle count (AFC) less than 4 at fertility\n             investigation\n\n          4. Known allergic reactions to the planned medications\n\n          5. Use of testicular sperm"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "38 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women suffering from infertility"
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01674894", 
            "org_study_id": "000063"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Frederiksberg", 
                    "country": "Denmark", 
                    "state": "Copenhagen"
                }, 
                "name": "Danish Fertility Clinic"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "2", 
        "official_title": "Kinetics in Time-lapse Culture of Human Preembryos", 
        "overall_contact": {
            "email": "DK0-Disclosure@ferring.com", 
            "last_name": "Clinical Development Support"
        }, 
        "overall_official": {
            "affiliation": "Ferring Pharmaceuticals", 
            "last_name": "Clinical Development Support", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Medicines Agency", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Time to 2. polar body extrusion in transferred embryos (only Intracellular Sperm Injection)", 
                "safety_issue": "No", 
                "time_frame": "Week 1 after oocyte retrieval"
            }, 
            {
                "measure": "Time for disappearance of pronuclei in transferred embryos", 
                "safety_issue": "No", 
                "time_frame": "Week 1 after oocyte retrieval"
            }, 
            {
                "measure": "Time for first cleavage in transferred embryos", 
                "safety_issue": "No", 
                "time_frame": "Week 1 after oocyte retrieval"
            }, 
            {
                "measure": "Time for cleavage to 3-cell embryo and 4-cell embryo in transferred embryos", 
                "safety_issue": "No", 
                "time_frame": "Week 1 after oocyte retrieval"
            }, 
            {
                "measure": "Scoring of blastomere even-size, fragmentation and multinucleation at 4-cell stage", 
                "safety_issue": "No", 
                "time_frame": "Week 1 after oocyte retrieval"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01674894"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Total dose of gonadotrophin used", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Gonadotrophin dose per oocyte retrieved", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Number of oocytes retrieved", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Number of fertilized and cleaved oocytes", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Number of preembryos with top quality", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Implantation rate", 
                "safety_issue": "No", 
                "time_frame": "2 months"
            }, 
            {
                "measure": "Ongoing pregnancy rate week 7", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Live birth rate", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }
        ], 
        "source": "Ferring Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ferring Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}